Insider filing · ALNY
Phillip A Sharp
Director
profile →
Alnylam Pharmaceuticals, Inc.
ALNY · Healthcare · 57 filings in 24 months
ticker →
Phillip A Sharp sold $3.1M of Alnylam Pharmaceuticals (ALNY)
Executed Jan 23 2025, disclosed Jan 24 2025, 1 day later.
Value, as filed
$3.1M
11,250 sh × $275.00
Executed
Jan 23 2025
the trade date, as filed
Disclosed
Jan 24 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PSPhillip A Sharp (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Alnylam Pharmaceuticals, Inc. (ALNY). The largest single filing was $3.1M of ALNY (11,250 sh × $275.00, as filed), executed Jan 23 2025.
The name
ALNYHealthcare · Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→